These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2991580)

  • 81. CVB translation: lessons from the polioviruses.
    Bonderoff JM; Lloyd RE
    Curr Top Microbiol Immunol; 2008; 323():123-47. PubMed ID: 18357768
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Inhibition of protein trafficking by coxsackievirus b3: multiple viral proteins target a single organelle.
    Cornell CT; Kiosses WB; Harkins S; Whitton JL
    J Virol; 2006 Jul; 80(13):6637-47. PubMed ID: 16775351
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Replication of Western equine encephalomyelitis virus. II. Cytoplasmic structure involved in the synthesis and development of the virions.
    Sreevalsan T; Allen PT
    J Virol; 1968 Oct; 2(10):1038-46. PubMed ID: 5723707
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells.
    Chung SK; Kim JY; Kim IB; Park SI; Paek KH; Nam JH
    Virology; 2005 Mar; 333(1):31-40. PubMed ID: 15708590
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Breakdown of HeLa cell DNA mediated by vaccinia virus.
    Parkhurst JR; Peterson AR; Heidelberger C
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3200-4. PubMed ID: 4522298
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site.
    Nobis P; Zibirre R; Meyer G; Kühne J; Warnecke G; Koch G
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2563-9. PubMed ID: 2999307
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Role of MIP-2 in coxsackievirus B3 myocarditis.
    Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
    J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses.
    Abdelnabi R; Geraets JA; Ma Y; Mirabelli C; Flatt JW; Domanska A; Delang L; Jochmans D; Kumar TA; Jayaprakash V; Sinha BN; Leyssen P; Butcher SJ; Neyts J
    PLoS Biol; 2019 Jun; 17(6):e3000281. PubMed ID: 31185007
    [TBL] [Abstract][Full Text] [Related]  

  • 89. mRNA translation is compartmentalized to the endoplasmic reticulum following physiological inhibition of cap-dependent translation.
    Lerner RS; Nicchitta CV
    RNA; 2006 May; 12(5):775-89. PubMed ID: 16540694
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Improved adenovirus vectors for infection of cardiovascular tissues.
    Havenga MJ; Lemckert AA; Grimbergen JM; Vogels R; Huisman LG; Valerio D; Bout A; Quax PH
    J Virol; 2001 Apr; 75(7):3335-42. PubMed ID: 11238859
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.
    Muir P; Kämmerer U; Korn K; Mulders MN; Pöyry T; Weissbrich B; Kandolf R; Cleator GM; van Loon AM
    Clin Microbiol Rev; 1998 Jan; 11(1):202-27. PubMed ID: 9457433
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.
    Anderson DR; Carthy CM; Wilson JE; Yang D; Devine DV; McManus BM
    J Virol; 1997 Nov; 71(11):8841-5. PubMed ID: 9343244
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Expression and distribution of the receptors for coxsackievirus B3 during fetal development of the Balb/c mouse and of their brain cells in culture.
    Xu R; Crowell RL
    Virus Res; 1996 Dec; 46(1-2):157-70. PubMed ID: 9029788
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.
    Shafren DR; Bates RC; Agrez MV; Herd RL; Burns GF; Barry RD
    J Virol; 1995 Jun; 69(6):3873-7. PubMed ID: 7538177
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
    Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
    J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.
    de Verdugo UR; Selinka HC; Huber M; Kramer B; Kellermann J; Hofschneider PH; Kandolf R
    J Virol; 1995 Nov; 69(11):6751-7. PubMed ID: 7474086
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus.
    Rossmann MG
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4625-7. PubMed ID: 3133655
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Transformation of a human poliovirus receptor gene into mouse cells.
    Mendelsohn C; Johnson B; Lionetti KA; Nobis P; Wimmer E; Racaniello VR
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7845-9. PubMed ID: 3020560
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Isolation of a receptor protein involved in attachment of human rhinoviruses.
    Tomassini JE; Colonno RJ
    J Virol; 1986 May; 58(2):290-5. PubMed ID: 3009846
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade.
    Crowell RL; Field AK; Schleif WA; Long WL; Colonno RJ; Mapoles JE; Emini EA
    J Virol; 1986 Feb; 57(2):438-45. PubMed ID: 3003376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.